[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![mupdatesbyscanx Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1926935883384553472.png) Market Updates by ScanX [@mupdatesbyscanx](/creator/twitter/mupdatesbyscanx) on x XXX followers
Created: 2025-07-17 13:04:28 UTC

Sun Pharmaceutical (SUNPHARMA)
on NSE: 1703.40 (+0.14%)

Sun Pharma Expands into China with New Subsidiary

View: Positive

Sun Pharmaceutical Industries Limited has established a new subsidiary, Sun Pharma (Hainan) Company Limited, in China. The subsidiary, registered on July 16, 2025, aims to localize products, collaborate with Chinese partners for production, and conduct sales in the Chinese market. Sun Pharma will maintain XXX% ownership of the subsidiary, either directly or through existing subsidiaries. This move provides direct access to the Chinese pharmaceutical market, potentially reducing costs and improving regulatory compliance.

Read more:

#Stocks #Market #SUNPHARMA

![](https://pbs.twimg.com/media/GwD73ZYW4AA7pbp.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945831971101503500/c:line.svg)

**Related Topics**
[china](/topic/china)
[nse](/topic/nse)
[$sunpharmans](/topic/$sunpharmans)

[Post Link](https://x.com/mupdatesbyscanx/status/1945831971101503500)